Logo image
Choline chloride in the treatment of cerebellar and spinocerebellar ataxia
Journal article   Peer reviewed

Choline chloride in the treatment of cerebellar and spinocerebellar ataxia

I.R. Livingstone, F.L. Mastaglia, R.J.T. Pennington and C. Skilbeck
Journal of the Neurological Sciences, Vol.50(2), pp.161-174
1981
url
Link to Published Version *Subscription may be requiredView

Abstract

The use of orally administered choline chloride in the treatment of cerebellar and spinocerebellar ataxia was investigated by a short-term double-blind crossover trial in 20 patients with ataxia. These patients, who included 7 with Friedreich's ataxia, 7 with mixed spinocerebellar ataxia and 6 with primary cerebellar degeneration received placebo and 6 g/day or 12 g/day of choline with crossover at 6 weeks. Serum choline levels were measured 1 h after the first daily dose. Mild but significant improvement in upper limb co-ordination was noted in 3 patients with Friedreich's ataxia, 3 with mixed ataxia and 4 patients with primary cerebellar degeneration. Improvement in gait and lower limb co-ordination was observed in only 2 patients (one with cerebellar ataxia and 1 with mixed ataxia). There was no correlation between serum choline levels and clinical response to choline. Choline chloride produces a mild but functionally significant improvement in motor co-ordination in some patients with cerebellar and spinocerebellar ataxia.

Details

UN Sustainable Development Goals (SDGs)

This output has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

Source: InCites

Metrics

InCites Highlights

These are selected metrics from InCites Benchmarking & Analytics tool, related to this output

Collaboration types
Domestic collaboration
International collaboration
Citation topics
1 Clinical & Life Sciences
1.5 Neuroscience
1.5.949 Cholinergic Systems
Web Of Science research areas
Clinical Neurology
Neurosciences
ESI research areas
Neuroscience & Behavior
Logo image